Effect of Insulin Glulisin on postprandial plasma glucose levels in obese subjectts with type 2 diabetes after a standard meal in comparison to Insulin Lispro
- Conditions
- Obese subjects with type 2 diabetes mellitus
- Registration Number
- EUCTR2005-005914-18-DE
- Lead Sponsor
- Diabetes-Centre Quakenbrueck
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Type 2 diabetic subjects
Age: > 30, < 80 years
Insulintherapy > 12 months
BMI: > 28, < 35 kg/m²
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnancy
Nursing
Medication known to influence insulin sensitivity
Alcohol abuse
Drug abuse
Psychiatric illness
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Area under the curve (AUC) plasma glucose 0-1 h;Secondary Objective: AUC plasma glucose 0-4 h (end)<br>Difference plasma glucose at 1 h postprandially<br>AUC plasma insulin 0-1 h<br>AUC plasma insulin 0-4 h (end);Primary end point(s): Area under the curve (AUC) plasma glucose 0-1 h
- Secondary Outcome Measures
Name Time Method